These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 38383444)

  • 21. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generative Models for De Novo Drug Design.
    Tong X; Liu X; Tan X; Li X; Jiang J; Xiong Z; Xu T; Jiang H; Qiao N; Zheng M
    J Med Chem; 2021 Oct; 64(19):14011-14027. PubMed ID: 34533311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LOGICS: Learning optimal generative distribution for designing de novo chemical structures.
    Bae B; Bae H; Nam H
    J Cheminform; 2023 Sep; 15(1):77. PubMed ID: 37674239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sc2Mol: a scaffold-based two-step molecule generator with variational autoencoder and transformer.
    Liao Z; Xie L; Mamitsuka H; Zhu S
    Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36576008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LibINVENT: Reaction-based Generative Scaffold Decoration for
    Fialková V; Zhao J; Papadopoulos K; Engkvist O; Bjerrum EJ; Kogej T; Patronov A
    J Chem Inf Model; 2022 May; 62(9):2046-2063. PubMed ID: 34460269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GenUI: interactive and extensible open source software platform for de novo molecular generation and cheminformatics.
    Sicho M; Liu X; Svozil D; van Westen GJP
    J Cheminform; 2021 Sep; 13(1):73. PubMed ID: 34563271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.
    Mouchlis VD; Afantitis A; Serra A; Fratello M; Papadiamantis AG; Aidinis V; Lynch I; Greco D; Melagraki G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GRELinker: A Graph-Based Generative Model for Molecular Linker Design with Reinforcement and Curriculum Learning.
    Zhang H; Huang J; Xie J; Huang W; Yang Y; Xu M; Lei J; Chen H
    J Chem Inf Model; 2024 Feb; 64(3):666-676. PubMed ID: 38241022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries.
    Swanson K; Walther P; Leitz J; Mukherjee S; Wu JC; Shivnaraine RV; Zou J
    Bioinformatics; 2024 Jul; 40(7):. PubMed ID: 38913862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probabilistic generative transformer language models for generative design of molecules.
    Wei L; Fu N; Song Y; Wang Q; Hu J
    J Cheminform; 2023 Sep; 15(1):88. PubMed ID: 37749655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perfect prosthetic heart valve: generative design with machine learning, modeling, and optimization.
    Danilov VV; Klyshnikov KY; Onishenko PS; Proutski A; Gankin Y; Melgani F; Ovcharenko EA
    Front Bioeng Biotechnol; 2023; 11():1238130. PubMed ID: 37781537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo drug design as GPT language modeling: large chemistry models with supervised and reinforcement learning.
    Ye G
    J Comput Aided Mol Des; 2024 Apr; 38(1):20. PubMed ID: 38647700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery.
    Singh S; Kumar R; Payra S; Singh SK
    Cureus; 2023 Aug; 15(8):e44359. PubMed ID: 37779744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformer-RL: A deep reinforcement learning library for conformer generation.
    Jiang R; Gogineni T; Kammeraad J; He Y; Tewari A; Zimmerman PM
    J Comput Chem; 2022 Oct; 43(27):1880-1886. PubMed ID: 36000759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Llamol: a dynamic multi-conditional generative transformer for de novo molecular design.
    Dobberstein N; Maass A; Hamaekers J
    J Cheminform; 2024 Jun; 16(1):73. PubMed ID: 38907298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive assessment of deep generative architectures for de novo drug design.
    Wang M; Sun H; Wang J; Pang J; Chai X; Xu L; Li H; Cao D; Hou T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34929743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PHOTONAI-A Python API for rapid machine learning model development.
    Leenings R; Winter NR; Plagwitz L; Holstein V; Ernsting J; Sarink K; Fisch L; Steenweg J; Kleine-Vennekate L; Gebker J; Emden D; Grotegerd D; Opel N; Risse B; Jiang X; Dannlowski U; Hahn T
    PLoS One; 2021; 16(7):e0254062. PubMed ID: 34288935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design.
    Wang Q; Wei Z; Hu X; Wang Z; Dong Y; Liu H
    Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37971970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.